Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Two-new-human-DNAJ-like-proteins

 Recombinant molecule encoding human protease nexin
We claim: 1. An isolated DNA molecule which encodes mature protease nexin-I (PN-I) alpha of FIG. 3 ...


 Method for design of substances that enhance memory and improve the quality of life
I claim: 1. Each of the compounds Gln Phe Phe-.gamma.-aminobutyric acid (SEQ ID NO: 20) Gln Phe Phe-...


 Amyloid .beta. protein (globular assembly and uses thereof)
What is claimed is: 1. An isolated, soluble, non-fibrillar amyloid .beta. protein assembly ...


 Chlamydia antigens and corresponding DNA fragments and uses thereof
The present invention provides purified and isolated polynucleotide molecules that encode the C...


 Methods of treating inflammatory bowel disease using cholera toxin B subunit
What is claimed is: 1. A method of treating inflammatory bowel disease in a subject diagnosed with ...


 Mammalian haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
1. Hemoglobin derivative compatible with human and non-human animal plasma, comprising hemoglobin ...


 Anti hepatitis C virus antibody and uses thereof
OF THE PRESENT INVENTION Accordingly, the technical problem of the invention is to provide means ...


 Chemical and/or biological decontamination system
OF THE INVENTION The present invention provides a composition that is effective in the ...


 Immunostimulant bacterial membrane fractions in cancer treatment
The invention claimed is: 1. A method of stimulating an immune response and/or inducing an ...


 Cloning and characterization of a human adenylyl cyclase
One aspect of the invention is an isolated and purified human type VI adenylyl cyclase (hAC6) ...


 Two new human DNAJ-like proteins

Details
Inventors: Au-Young, Janice; Lal, Preeti; Bandman, Olga;
Assignee: Incyte Pharmaceuticals, Inc. (Palo Alto, CA)
Primary Examiner: Prouty; Rebecca E.
Assistant Examiner: Slobodyansky; Elizabeth
Attorney, Agent or Firm: Mohan-Peterson; Sheela Incyte Pharmaceuticals, Inc.

The invention provides a two new human DnaJ-like proteins (HSPJ1 or HSPJ2) and polynucleotides which identify and encode HSPJ1 or HSPJ2. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of HSPJ1 or HSPJ2.

DETAILED DESCRIPTION What is claimed is: 1.
An isolated and purified polynucleotide sequence encoding the amino acid sequence of SEQ ID NO:1.
2.
A composition comprising the polynucleotide sequence of claim 1.
3.
A polynucleotide sequence which is fully complementary to the polynucleotide sequence of claim 2.
4.
An isolated and purified polynucleotide sequence comprising SEQ ID NO:2.
5.
A composition comprising the polynucleotide sequence of claim 4.
6.
A polynucleotide sequence which is fully complementary to the polynucleotide sequence of claim 4.
7.
An expression vector containing the polynucleotide sequence of claim 1.
8.
A host cell containing the vector of claim 7.
9.
A method for producing a polypeptide comprising the amino acid sequence of SEQ ID NO:1, the method comprising the steps of: a) culturing the host cell of claim 8 under conditions suitable for the expression of the polypeptide; and b) recovering the polypeptide from the host cell culture.




Description:
FIELD OF THE INVENTION This invention relates to nucleic acid and amino acid sequences of two new human DnaJ-like proteins and to the use of these sequences in the diagnosis, prevention, and treatment of cancer and inflammatory and immune disorders.
BACKGROUND OF THE INVENTION Induction of heat shock proteins (Hsps), a class of molecular chaperones, is a physiological and biochemical response to abrupt increases in temperature or exposure to a variety of other metabolic insults including heavy metals, amino acid analogs, toxins, and oxidative stress.
This response occurs in all prokaryotic and eukaryotic cells and is characterized by repression of normal protein synthesis and initiation of transcription of Hsp-encoding genes.
Under normal or nonstressed conditions, constitutively expressed Hsps facilitate proper protein folding and maturation, promote protein translocation across membranes, and regulate hormone receptor and protein kinase activity (Hightower, L.
E.
, et al.
(1991) Cell, 66: 191-197).
During cellular stress, Hsps form a complex with proteins that misfold or unfold, either "rescuing" these proteins from irreversible damage or increasing their susceptibility to proteolytic attack



Related patents
  Method and compositions for the treatment of autoimmune disease using heat shock proteins
OF THE INVENTION Methods and compositions for the treatment of autoimmune disease are described. The invention is based, in part, on newly discovered treatment regimens ...
  Recombinant antibody and antibody fragment
OF THE INVENTION This application is based on Japanese applications No. 2000-59508 filed on Mar. 3, 2000 and No. 2000-401563 filed on Dec. 28, 2000, the entire contents ...
  Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
PspC (see FIGS. 1, 2, 3, 4, 5, 11, 12, 13, 14, 15) is one of three designations for a pneumococcal surface protein which is PspA-like, and whose gene is present in ...
  Large DNA cloning system based on yeast artificial chromosomes
OF THE INVENTION While the specification concludes with claims particularly pointing out and distinctly claiming the subject matter regarded as forming the present ...
  Rat neurotrophic factor receptor, GFRα-4
OF THE INVENTION Thus, the present invention relates to a nucleic acid molecule encoding a mammalian GDNF family receptor α-4 (GFRα-4) or an immunologically ...
  Polypeptide and protein derivatives and process for their preparation
What we claim is: 1. A method of producing a composition containing modified protein or polypeptide molecules, or salts thereof, wherein said modified protein or ...
  Single chain MHC complexes and uses thereof
The present invention relates to novel complexes of major histocompability complex (MHC) molecules (class I or II), e.g., empty single chain MHC class II complexes, ...
  IL-1/TNF-.alpha.-activated kinase (ITAK), and methods of making and using the same
The present invention provides nucleic acid and amino acid sequences of protein kinases, preferably human, that interact with at least one post-receptor intracellular ...
  DNA encoding IL-1 receptor accessory protein
What is claimed is: 1. An isolated polynucleotide comprising SEQ ID NO:1 wherein the nucleic acid at 1792 is A or C. 2. An isolated polynucleotide comprising a nucleic ...
  Human immunodeficiency virus immunogenic composition
The present invention relates to an HLA-based vaccine against HIV. Vaccines of the invention, which induce salutary anti-HIV immune responses, can be designed based on ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved